These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36833590)

  • 1. Insights from COVID-19: Reflecting on the Promotion of Long-Term Health Policies in China.
    Wu Q; Chen B; Zhu J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 3. Temporal and Emotional Variations in People's Perceptions of Mass Epidemic Infectious Disease After the COVID-19 Pandemic Using Influenza A as an Example: Topic Modeling and Sentiment Analysis Based on Weibo Data.
    Dai J; Lyu F; Yu L; He Y
    J Med Internet Res; 2023 Nov; 25():e49300. PubMed ID: 37917144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic evolution of policy mix in response to COVID-19: Practice from China.
    Du L; Lu W
    PLoS One; 2023; 18(9):e0291633. PubMed ID: 37768975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Social Effects on Employment Promotion Policies for College Graduates Based on Data Mining for Online Use Review in China during the COVID-19 Pandemic.
    Chen T; Rong J; Peng L; Yang J; Cong G; Fang J
    Healthcare (Basel); 2021 Jul; 9(7):. PubMed ID: 34356224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding "Internet Plus Healthcare" in China: Policy Text Analysis.
    Yang F; Shu H; Zhang X
    J Med Internet Res; 2021 Jul; 23(7):e23779. PubMed ID: 34309581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on Monetary Policy Implementation and Industrial Structure Transformation Under COVID-19-Evidence From Eight Economic Zones in Mainland China.
    Zhou B; Wang S; Gao H; Wang H
    Front Public Health; 2022; 10():865699. PubMed ID: 35669741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the nexus between COVID-19 pandemic-driven economic crisis and economic policy: lesson learned and challenges.
    Chang L; Mohsin M; Iqbal W
    Environ Sci Pollut Res Int; 2023 Feb; 30(9):22145-22158. PubMed ID: 36282386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissemination and Refutation of Rumors During the COVID-19 Outbreak in China: Infodemiology Study.
    Chen B; Chen X; Pan J; Liu K; Xie B; Wang W; Peng Y; Wang F; Li N; Jiang J
    J Med Internet Res; 2021 Feb; 23(2):e22427. PubMed ID: 33493124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topic and Trend Analysis of Weibo Discussions About COVID-19 Medications Before and After China's Exit from the Zero-COVID Policy: Retrospective Infoveillance Study.
    Lan D; Ren W; Ni K; Zhu Y
    J Med Internet Res; 2023 Oct; 25():e48789. PubMed ID: 37889532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authorized, clear and timely communication of risk to guide public perception and action: lessons of COVID-19 from China.
    Gong N; Jin X; Liao J; Li Y; Zhang M; Cheng Y; Xu D
    BMC Public Health; 2021 Aug; 21(1):1545. PubMed ID: 34384378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Study on International Research Hotspots and National-Level Policy Keywords of Dynamic Disaster Monitoring and Early Warning in China (2000-2021).
    Gao J; Zhang W; Yang C; Wang R; Shao S; Li J; Zhang L; Li Z; Liu S; Si W
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.
    Ding D; Zhang R
    Front Public Health; 2022; 10():857003. PubMed ID: 35359767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COVID-19 pandemic: global epidemiological trends and China's subsequent preparedness and responses].
    Guo Y; Huang YM; Huang J; Jin YZ; Jiang W; Liu PL; Liu FJ; Ma JX; Ma JY; Wang Y; Xie Z; Yin H; Zhao CS; Zhou SD; Zhang J; Zheng ZJ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):642-647. PubMed ID: 32164401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating China's mental health policy on local-level promotion and implementation: a case study of Liuyang Municipality.
    Zhou W; Yu Y; Zhao X; Xiao S; Chen L
    BMC Public Health; 2019 Jan; 19(1):24. PubMed ID: 30616607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining and quantitative evaluation of COVID-19 policy tools in China.
    Liu J; Li N; Cheng L
    PLoS One; 2023; 18(4):e0284143. PubMed ID: 37027438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.